Table 2.
Assessments at different time points
| Screening | Pretreatment | During treatment | Post-treatment | 3-month follow-up | 12-month follow-up | |
| Clinician-rated instruments | ||||||
| SCID-5 (OCD) | X | X | X | X | X | |
| Y-BOCS | X | X | X | X | X | X |
| CGI-S | X | X | X | X | ||
| CGI-I | X | X | X | |||
| GAF | X | X | X | X | ||
| SMURF | X | X | X | X | ||
| PEAS | X | X | ||||
| MADRS-S | X | |||||
| MINI | X | |||||
| Self-rated instruments | ||||||
| Y-BOCS | X | X | X | X | X | |
| Y-BOCS checklist | X | |||||
| OCI-R | X | X | X | X | X | |
| EQ-5D | X | X | X | X | X | |
| EQ-5D index | X | X | X | X | X | |
| AUDIT | X | |||||
| DUDIT | X | |||||
| MADRS-S | X | X | X | X | X | |
| PHQ9 | X | |||||
| SDS | X | X | X | X | X | |
| ASRS | X | |||||
| ISI | X | X | ||||
| TIC-P | X | X | X | X | ||
| TCS | X | |||||
| WAI-SF | X | X | ||||
ASRS, Adult ADHD Self-Report Scale; AUDIT, Alcohol Use Disorder Identification Test; CGI-I, Clinical Global Impression-Improvement Scale; CGI-S, Clinical Global Impression-Severity Scale; DUDIT, Drug Use Disorders Identification Test; EQ-5D, EuroQol 5 Dimension Scale; GAF, Global Assessment of Functioning; ISI, Insomnia Severity Index; MADRS-S, Montgomery-Åsberg Depression Rating Scale; MINI, Mini International Neuropsychiatric Interview; OCI-R, Obsessive–Compulsive Inventory-Revised; PEAS, Patient Exposure/Response Prevention Adherence Scale; PHQ9, Patient Health Questionnaire; SCID-5, Structured Clinical Interview for DSM-5 Disorders (OCD), obsessive–compulsive disorder; SCID-5, The Structured Clinical Interview for DSM-5; SDS, Sheehan Disability Scale; SMURF, Safety Monitoring Uniform Report Form; TCS, Treatment Credibility Scale; TIC-P, Treatment Inventory of Costs in Psychiatric Patients; WAI-SF, Working Alliance Inventory – Short Form; Y-BOCS, Yale-Brown Obsessive Compulsive Scale.